DNA vaccine-encoded glycoprotein B of HSV-1 fails to protect chronic morphine-treated mice against HSV-1 challenge

Jamali, A and Roostaee, M.H and Soleimanjahi, H and Ghaderi Pakdel, F and Bamdad, T (2007) DNA vaccine-encoded glycoprotein B of HSV-1 fails to protect chronic morphine-treated mice against HSV-1 challenge. Comparative Immunology, Microbiology and Infectious Diseases, 30 (2). pp. 71-80.

[img]
Preview
Text
DNA_vaccine-encoded_glycoprotein_B_of_HSV-1-2007.pdf

Download (136kB) | Preview
Official URL: https://www.scopus.com/inward/record.uri?eid=2-s2....

Abstract

The use of morphine has been demonstrated to increase susceptibility to infections. Herpes simplex virus type 1 (HSV-1) is a highly successful pathogen among immunocompromised individuals. In the present study, due to the importance of HSV vaccination in morphine abusers, the effects of chronic morphine exposure on the host response to a HSV-1 gB DNAbased vaccine have been investigated. The study is addressing an important aspect of vaccine development among the susceptible (immunocompromised) hosts. BALB/c mice were exposed to morphine over 11 days. They were then vaccinated with DNA vaccine or KOS strain as a live vaccine. The findings showed that the morphine-treated animals failed to respond to DNA vaccination evaluated by the anti-HSV gB antibody titer, delayed type hypersensitivity (DTH) and lethal HSV-1 challenge. Under the same conditions, the KOS vaccine showed a reduced

Item Type: Article
Additional Information: cited By 12
Uncontrolled Keywords: Morphine; Herpes simplex virus; DNA vaccine
Subjects: R Medicine > R Medicine (General)
Depositing User: Unnamed user with email gholipour.s@umsu.ac.ir
Date Deposited: 19 Aug 2017 09:06
Last Modified: 16 Feb 2019 10:48
URI: http://eprints.umsu.ac.ir/id/eprint/1408

Actions (login required)

View Item View Item